CytoReason vs Geneyx Genomex
CytoReason vs Geneyx Genomex, compared side by side on 19 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: CytoReason is on 68/100 and Geneyx Genomex on 55/100.
Where each one leads
CytoReason
- our overall score: 68/100 against 55/100
- headcount: 116 against 31
- funding raised: $128M against $10.0M
- LinkedIn following: 12,830 against 6,977
Geneyx Genomex
- agent readiness: 50/100 against 21/100
At a glance
| Measure | CytoReason | Geneyx Genomex |
|---|---|---|
| What it is | Develops a computational model of the human body for drug discovery and development. | Harnessing genetic data for digital insights in rare and germline disorders. |
| Category | Healthcare, Drug Discovery, Clinical Development, Biomarkers | Healthcare, Genomics, Diagnostics, Clinical |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | Software |
| Founded | 2016 | 2018 |
| Headquarters | Tel Aviv, Israel | Tel Aviv, Israel |
| Status | Active | Inactive |
Size, funding and growth
| Measure | CytoReason | Geneyx Genomex |
|---|---|---|
| Employees | 116 | 31 |
| Headcount growthLast 12 months | +13.7% | +12.1% |
| Total funding | $128M | $10.0M |
| Latest round | Series B | Seed |
| LinkedIn followers | 12,830 | 6,977 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | CytoReason | Geneyx Genomex |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 68/100 | 55/100 |
| Traction | 60/100 | 50/100 |
| Team | 70/100 | 70/100 |
| Search visibility | 30/100 | 25/100 |
| Quality | 78/100 | 58/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (21/100) | D (50/100) |
| Domain ratingLink authority, 0-100 | 40/100 | 44/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | CytoReason | Geneyx Genomex |
|---|---|---|
| Hosting | Not detected | Google Cloud |
| Analytics | Segment | Not detected |
CytoReason vs Geneyx Genomex: common questions
Which is better, CytoReason or Geneyx Genomex?
On our 0-100 score CytoReason rates higher (68/100 against 55/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 19 data points above: read the rows that match what you are buying for.
How do CytoReason and Geneyx Genomex compare on the numbers?
CytoReason leads on our overall score (68/100 against 55/100), headcount (116 against 31), funding raised ($128M against $10.0M), LinkedIn following (12,830 against 6,977). Geneyx Genomex leads on agent readiness (50/100 against 21/100).
Read the full CytoReason review and pricing or the Geneyx Genomex review and pricing. You can also browse other CytoReason alternatives we track.